Startup Mozart targets autoimmune, inflammatory diseases
Biopharmaceutical startup Mozart Therapeutics has launched with a focus on developing therapeutics for autoimmune and inflammatory diseases. Read More
DNA Script adds $165M to coffers
DNA Script has raised $165 million in a series C financing round led by Coatue Management and Catalio Capital Management. Read More
CEM launches Prodigy HPLC system
CEM has unveiled its Prodigy preparative high-performance liquid chromatography (HPLC) system. Read More
PerkinElmer unveils Signals Research Suite
PerkinElmer has introduced Signals Research Suite, a cloud-based informatics platform geared toward pharmaceutical and industrial customers. Read More
Roche releases genomic profiling kit for cancer research
Roche has released a new genomic profiling kit for cancer research called the Avenio Tumor Tissue Comprehensive Genomic Profiling kit. Read More
Polaris Biology launches a new mass cytometer
Polaris Biology has released a new mass cytometry system called Starion. The cytometer allows for analysis of more than 40 parameters at a single-cell resolution. Read More
Canbridge inks collaboration, licensing agreement with Scriptr Global
Canbridge Pharmaceuticals has signed an exclusive global research collaboration and licensing agreement with Scriptr Global for that company's Stitchr ribozyme-mediated RNA assembly platform for the development of gene therapies for dystrophinopathies. Read More
10x Genomics opens Singapore manufacturing facility
10x Genomics has opened a manufacturing and commercial facility in Singapore, expanding its reach into the Asia-Pacific region. The facility is the company's first outside of the U.S. Read More
Researchers develop 'three-headed hydra' for anti-cancer activity
A "three-headed hydra" significantly improves efficacy in targeted protein degradation, according to research published October 21 in Nature Chemical Biology Read More
I-Mab establishing new site in San Diego
I-Mab is establishing a new site in San Diego that will focus on translational medicine and formulation research, the company announced. I-Mab did not indicate when the site would be operational. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter